
News|Articles|June 22, 2026
Faricimab (Vabysmo® , Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement
This is a promotional supplement commissioned by Roche Products Limited.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement






















